Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02115425 · ClinicalTrials.gov registry record
Calibrate Samsung's BIA to Meseaure Body Composition
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 421
- Enrollment target
NCT02115425: Completed study, sponsored by Pennington Biomedical Research Center.
NCT02115425 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 421 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02115425 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 421 participants
- Enrollment target
Study Summary
The purpose of this study is to collect body composition data using bioimpedance analysis (Samsung) and DXA (GE Medical). Both of the methods are explained in more detail in section 5 of this consent. The data collected will help Samsung improve the products the company offers.
Primary Outcome
The study will be conducted in two overlapping phases. In Phase I, approximately 300 adult subjects (\>18 to 80 yrs, equal numbers of female and male) will be recruited to take part in this study as detailed below: (1) Underweight (BMI\<18.5 k/m2), 50 subjects. (2) Normal-Overweight (18.5-30), 150 subjects. (3) Obese (\>30), 100 subjects. Phase II, planned to start later this spring and summer, will involve evaluation of children and 100 subjects (10-\</=18 yrs, equal numbers of female and male
Interventions
- OTHER Body Measurements
- OTHER Whole Body DXA Scan
- OTHER Bioelectrical Impedance Analysis (BIA)
- OTHER add name here
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 421 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-12 |
What the finished NCT02115425 record still lists
NCT02115425 is an observational study that tracks outcomes without assigning an intervention. The registered 421 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Body Measurements is the first listed.
NCT02115425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02115425 about?
NCT02115425 is a clinical study titled "Calibrate Samsung's BIA to Meseaure Body Composition". The purpose of this study is to collect body composition data using bioimpedance analysis (Samsung) and DXA (GE Medical). Both of the methods are explained in more detail in section 5 of this consent. The data collected will help Samsung improve the products the company offers.
What is the current status of trial NCT02115425?
This trial is currently completed. The enrollment target is 421 participants. The study started on 2014-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02115425?
The interventions under investigation include: Body Measurements (OTHER), Whole Body DXA Scan (OTHER), Bioelectrical Impedance Analysis (BIA) (OTHER), add name here (OTHER).
Who is sponsoring clinical trial NCT02115425?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05976763 · 421 participants · Phase 3
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- NCT07114601 · 421 participants · Phase 1
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- NCT04763356 · 422 participants · NA
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
- NCT06837246 · 422 participants · NA
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia